Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal meperidine versus dexmedetomidine for post-cesarean pain after spinal anesthesia
IRCT20240221061070N7Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pethidine, dexmedetomidine and bupivacaine in postoperative pain (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Postoperative pain intensity. Started Oct 2025; status: completed.
02
Drugs
pethidinedexmedetomidinebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20240221061070N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240221061070N7.